GPT and metabolic syndrome: Serum ALT activity is therefore regarded as a reliable and sensitive marker of liver disease and an indicator of overall health, particularly in the context of obesity, metabolic syndrome, and the presence of cardiovascular disease, as many patients affected by these conditions also are at risk of having non-alcoholic fatty liver disease [14].